WGRX Wellgistics Health, Inc.

Nasdaq Wholesale-Drugs, Proprietaries & Druggists' Sundries DE CIK: 0002030763
AI RATING
STRONG_SELL
97% Confidence

Investment Thesis

Wellgistics is in severe financial distress with negative stockholders' equity (-$12.4M), negative gross margins (-27.5%), and critically low cash reserves ($42.6K). The company is burning cash operationally while generating massive losses, suggesting insolvency risk and inability to sustain operations without immediate capital infusion or restructuring.

Strengths

  • + Revenue growing 28.7% YoY demonstrating market demand
  • + Operating in healthcare/pharmaceutical distribution sector with structural demand
  • + Asset base of $30.5M provides some liquidation value

Risks

  • ! Negative stockholders' equity indicates technical insolvency
  • ! Negative gross margin (-27.5%) means losing money on every sale
  • ! Critically low cash position ($42.6K) insufficient for operations
  • ! Severe liquidity crisis with current ratio of 0.09x
  • ! Operating cash flow negative (-$10.9M) indicating ongoing burn
  • ! Net losses deteriorating sharply (-1,377% YoY decline)
  • ! Long-term debt of $23.5M against minimal cash and negative equity

Key Metrics to Watch

Financial Metrics

Revenue
23.3M
Net Income
-101.3M
EPS (Diluted)
$-1.43
Free Cash Flow
-10.9M
Total Assets
30.5M
Cash
42.6K

Profitability Ratios

Gross Margin -27.5%
Operating Margin -401.7%
Net Margin -433.9%
ROE N/A
ROA -332.5%
FCF Margin -46.5%

Balance Sheet & Liquidity

Current Ratio
0.09x
Quick Ratio
0.04x
Debt/Equity
N/A
Debt/Assets
140.9%
Interest Coverage
N/A
Long-term Debt
23.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-19T03:45:21.446511 | Data as of: 2025-12-31 | Powered by Claude AI